Sunday, July 25, 2021
Home Tags Lupin

Tag: Lupin

Lupin gets warning letter from USFDA for Somerset facility

Drug firm Lupin on Sunday said it has received a warning letter from the US health regulator for its Somerset facility in the US.

Lupin launches Digital Asthma Educator platform for patients

Mumbai: Global pharma major Lupin Limited (Lupin) on Monday announced the launch of its Digital Asthma Educator platform for guiding patients on the correct technique of using inhalers.

Lupin launches generic drug for treatment of Pulmonary disease

Global pharma major, Lupin Limited, announced the launch of the authorized generic version of Brovana (arformoterol tartrate) inhalation solution 15 mcg/2 mL,...

USFDA accepts application from Lupin for Pegfilgrastim Biosimilar

Lupin announced that the USFDA has accepted the Biologics License Application (BLA) for its proposed biosimilar to Neulasta (pegfilgrastim) through a filing...

Lupin, Sun, Jubilant recall generic medicines in US

Lupin, Sun Pharma and Jubilant Cadista are recalling different products in the US, the world’s largest market for medicines, for different reasons.

These 4 Pharma companies invest in ABCD Technologies

Four pharma major companies have subscribed to partnership interest in ABCD Technologies LLP (to be renamed as IndoHealth Services LLP).

Focus on quality to change perception on drugs from India

Focus on quality to change perception on drugs from India: Pharma chiefs In the early days of the pandemic...

Pharma Industry welcomes PLI Scheme, awaits implementation details

Pharma Industry welcomes PLI Scheme, awaits implementation details The Union Cabinet’s decision to approve the Production Linked Incentive (PLI) 2.0...

Lupin gets USFDA nod to market generic Droxidopa capsules

Global pharma major Lupin Limited has received approval for its droxidopa capsules, 100 mg, 200 mg, and 300 mg, from the United...

Lupin launches Posaconazole Delayed-Release Tablets

Lupin announced the launch of Posaconazole Delayed-Release Tablets, 100 mg, after its alliance partner AET Pharma US (part of Tiefenbacher Group) received...

Lupin, Aurobindo units recall medicines in US market

New Delhi: US-based units of drug firms Lupin and Aurobindo Pharma are recalling certain products in the American market, as per the latest enforcement report of...

Lupin gets US FDA nod to market generic Tavaborole topical solution

Global pharma major Lupin Limited has received approval for its tavaborole topical solution, 5%, from the United States Food and Drug Administration...

Lupin gets USFDA nod for Kidney disease drug

Lupin has received approval for its Sevelamer Carbonate Tablets, 800 mg, from the United States Food and Drug Administration (USFDA), to market...

Lupin gets tentative USFDA nod for type 2 diabetes drug

Lupin has received tentative approval for its Empagliflozin and Metformin Hydrochloride Extended Release (ER) Tablets, 5 mg/1000 mg, 10 mg/1000 mg, 12.5...

Lupin gets USFDA approval for bacterial infection drug

Lupin has received the United States Food and Drug Administration (USFDA) approval for its Sulfamethoxazole and Trimethoprim Oral Suspension USP, 200 mg/40...

Lupin launches Kidney treatment tablets

Lupin Limited, global pharmaceutical company, announced the launch of mycophenolate mofetil tablets USP, 500 mg, after Lupin’s alliance partner Concord Biotech Limited...

Lupin launches generic Meloxicam capsules

Lupin Limited, global pharmaceutical company, announced the launch of the United States Food and Drug Administration (USFDA) approved meloxicam capsules, 5 mg,...

Lupin launches Meloxicam Capsules

Lupin announced the launch of Meloxicam Capsules, 5 mg, and 10 mg, having received an approval from the United States Food and...

Lupin gets tentative nod from USFDA for Efinaconazole Topical Solution

Lupin has received tentative approval for its Efinaconazole Topical Solution, 10%, from the United States Food and Drug Administration (USFDA), to market...

Lupin gets USFDA approval for Penicillamine tablets

Pharma major Lupin Limited has received approval from the United States Food and Drug Administration (FDA) to market for penicillamine tablets USP,...

Lupin gets 13 observations post USFDA inspection

USFDA concluded an inspection of Lupin’s subsidiary Novel Laboratories based in Somerset, NJ. The inspection commenced on September 10, 2020, and concluded...

Sun Pharma recalls generic diabetes drug: USFDA

New Delhi: Leading drug maker Sun Pharma is recalling 747 bottles of generic diabetes drug in the US due to possibility of the affected lot containing...

Lupin gets USFDA approval for drug to treat multiple sclerosis

Lupin has received approval for its dimethyl fumarate delayed-release capsules, 120 mg and 240 mg, from the United States Food and Drug...

Lupin launches Lapatinib Tablets

Lupin announced the launch of Lapatinib Tablets, 250 mg, after Lupin’s alliance partner Natco Pharma received final approval for its ANDA from...

Latest posts

Report of Govt Analyst and CDL must give factual data (Part-1)

Report of Govt Analyst and CDL must give factual data The Drugs and Cosmetics Act, 1940, provides for...

Authors

42 POSTS0 COMMENTS
30 POSTS0 COMMENTS
15 POSTS0 COMMENTS
11 POSTS0 COMMENTS
5 POSTS0 COMMENTS
5 POSTS0 COMMENTS
4 POSTS0 COMMENTS
4 POSTS0 COMMENTS
4 POSTS0 COMMENTS
3 POSTS0 COMMENTS
2 POSTS0 COMMENTS
2 POSTS0 COMMENTS
1 POSTS0 COMMENTS
1 POSTS0 COMMENTS
1 POSTS0 COMMENTS
1 POSTS0 COMMENTS